The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Glucocorticoids are given in relatively large doses for the treatment and prevention of cerebral edema in patients with brain tumors and in some patients with bacterial meningitis.
The global Glucocorticoids market was valued at US$ 4850 million in 2023 and is anticipated to reach US$ 6690.5 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
Topical corticosteroids are steroid medications that are applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids come in many different forms, including creams, lotions, and gels. Topical steroids are used to treat skin conditions such as rashes, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market owing to growing geriatric population across the world, increase in skin conditions, and prolonging duration. Increasing prevalence of skin-related disorders and rising incidence of rashes, dermatitis, itching, eczema, and psoriasis are boosting the growth of the corticosteroid market.
This report aims to provide a comprehensive presentation of the global market for Glucocorticoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucocorticoids.
Report Scope
The Glucocorticoids market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucocorticoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucocorticoids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Pfizer
- Novartis
- Aspen
- Euroapi
- Sanofi
- Avik Pharmaceutical Limited
- Symbiotec
- Cipla
- Abbott Laboratories
- Tianjin Tianyao Pharmaceuticals Co., Ltd.
- Zhejiang Xianju Pharmaceutical Co.,Ltd
- Shandong Xinhua Pharmaceutical Company Limited
- Yangzi River Pharmaceutical Group
Segment by Type
- Cortisone
- Prednisone
- Prednisolone
- Methylprednisolone
- Dexamethasone
- Betamethasone
- Hydrocortisone
- Others
Segment by Application
- Anti-inflammatory
- Immunosuppressive
- Vasoconstrictive
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucocorticoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucocorticoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Glucocorticoids Market Overview
1.1 Product Overview and Scope of Glucocorticoids
1.2 Glucocorticoids Segment by Type
1.2.1 Global Glucocorticoids Market Value Comparison by Type (2024-2030)
1.2.2 Cortisone
1.2.3 Prednisone
1.2.4 Prednisolone
1.2.5 Methylprednisolone
1.2.6 Dexamethasone
1.2.7 Betamethasone
1.2.8 Hydrocortisone
1.2.9 Others
1.3 Glucocorticoids Segment by Application
1.3.1 Global Glucocorticoids Market Value by Application: (2024-2030)
1.3.2 Anti-inflammatory
1.3.3 Immunosuppressive
1.3.4 Vasoconstrictive
1.4 Global Glucocorticoids Market Size Estimates and Forecasts
1.4.1 Global Glucocorticoids Revenue 2019-2030
1.4.2 Global Glucocorticoids Sales 2019-2030
1.4.3 Global Glucocorticoids Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glucocorticoids Market Competition by Manufacturers
2.1 Global Glucocorticoids Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glucocorticoids Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glucocorticoids Average Price by Manufacturers (2019-2024)
2.4 Global Glucocorticoids Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucocorticoids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucocorticoids, Product Type & Application
2.7 Glucocorticoids Market Competitive Situation and Trends
2.7.1 Glucocorticoids Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucocorticoids Players Market Share by Revenue
2.7.3 Global Glucocorticoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucocorticoids Retrospective Market Scenario by Region
3.1 Global Glucocorticoids Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glucocorticoids Global Glucocorticoids Sales by Region: 2019-2030
3.2.1 Global Glucocorticoids Sales by Region: 2019-2024
3.2.2 Global Glucocorticoids Sales by Region: 2025-2030
3.3 Global Glucocorticoids Global Glucocorticoids Revenue by Region: 2019-2030
3.3.1 Global Glucocorticoids Revenue by Region: 2019-2024
3.3.2 Global Glucocorticoids Revenue by Region: 2025-2030
3.4 North America Glucocorticoids Market Facts & Figures by Country
3.4.1 North America Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glucocorticoids Sales by Country (2019-2030)
3.4.3 North America Glucocorticoids Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucocorticoids Market Facts & Figures by Country
3.5.1 Europe Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glucocorticoids Sales by Country (2019-2030)
3.5.3 Europe Glucocorticoids Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucocorticoids Market Facts & Figures by Country
3.6.1 Asia Pacific Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glucocorticoids Sales by Country (2019-2030)
3.6.3 Asia Pacific Glucocorticoids Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Glucocorticoids Market Facts & Figures by Country
3.7.1 Latin America Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glucocorticoids Sales by Country (2019-2030)
3.7.3 Latin America Glucocorticoids Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucocorticoids Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glucocorticoids Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glucocorticoids Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucocorticoids Sales by Type (2019-2030)
4.1.1 Global Glucocorticoids Sales by Type (2019-2024)
4.1.2 Global Glucocorticoids Sales by Type (2025-2030)
4.1.3 Global Glucocorticoids Sales Market Share by Type (2019-2030)
4.2 Global Glucocorticoids Revenue by Type (2019-2030)
4.2.1 Global Glucocorticoids Revenue by Type (2019-2024)
4.2.2 Global Glucocorticoids Revenue by Type (2025-2030)
4.2.3 Global Glucocorticoids Revenue Market Share by Type (2019-2030)
4.3 Global Glucocorticoids Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glucocorticoids Sales by Application (2019-2030)
5.1.1 Global Glucocorticoids Sales by Application (2019-2024)
5.1.2 Global Glucocorticoids Sales by Application (2025-2030)
5.1.3 Global Glucocorticoids Sales Market Share by Application (2019-2030)
5.2 Global Glucocorticoids Revenue by Application (2019-2030)
5.2.1 Global Glucocorticoids Revenue by Application (2019-2024)
5.2.2 Global Glucocorticoids Revenue by Application (2025-2030)
5.2.3 Global Glucocorticoids Revenue Market Share by Application (2019-2030)
5.3 Global Glucocorticoids Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Glucocorticoids Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Glucocorticoids Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Aspen
6.3.1 Aspen Corporation Information
6.3.2 Aspen Description and Business Overview
6.3.3 Aspen Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aspen Glucocorticoids Product Portfolio
6.3.5 Aspen Recent Developments/Updates
6.4 Euroapi
6.4.1 Euroapi Corporation Information
6.4.2 Euroapi Description and Business Overview
6.4.3 Euroapi Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Euroapi Glucocorticoids Product Portfolio
6.4.5 Euroapi Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Glucocorticoids Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Avik Pharmaceutical Limited
6.6.1 Avik Pharmaceutical Limited Corporation Information
6.6.2 Avik Pharmaceutical Limited Description and Business Overview
6.6.3 Avik Pharmaceutical Limited Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Avik Pharmaceutical Limited Glucocorticoids Product Portfolio
6.6.5 Avik Pharmaceutical Limited Recent Developments/Updates
6.7 Symbiotec
6.6.1 Symbiotec Corporation Information
6.6.2 Symbiotec Description and Business Overview
6.6.3 Symbiotec Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Symbiotec Glucocorticoids Product Portfolio
6.7.5 Symbiotec Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cipla Glucocorticoids Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Corporation Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abbott Laboratories Glucocorticoids Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Tianjin Tianyao Pharmaceuticals Co., Ltd.
6.10.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corporation Information
6.10.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Description and Business Overview
6.10.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Product Portfolio
6.10.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.11 Zhejiang Xianju Pharmaceutical Co.,Ltd
6.11.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information
6.11.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Description and Business Overview
6.11.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Product Portfolio
6.11.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
6.12 Shandong Xinhua Pharmaceutical Company Limited
6.12.1 Shandong Xinhua Pharmaceutical Company Limited Corporation Information
6.12.2 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Description and Business Overview
6.12.3 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Product Portfolio
6.12.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
6.13 Yangzi River Pharmaceutical Group
6.13.1 Yangzi River Pharmaceutical Group Corporation Information
6.13.2 Yangzi River Pharmaceutical Group Glucocorticoids Description and Business Overview
6.13.3 Yangzi River Pharmaceutical Group Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Yangzi River Pharmaceutical Group Glucocorticoids Product Portfolio
6.13.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucocorticoids Industry Chain Analysis
7.2 Glucocorticoids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucocorticoids Production Mode & Process
7.4 Glucocorticoids Sales and Marketing
7.4.1 Glucocorticoids Sales Channels
7.4.2 Glucocorticoids Distributors
7.5 Glucocorticoids Customers
8 Glucocorticoids Market Dynamics
8.1 Glucocorticoids Industry Trends
8.2 Glucocorticoids Market Drivers
8.3 Glucocorticoids Market Challenges
8.4 Glucocorticoids Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
